Co-Authors
This is a "connection" page, showing publications co-authored by Benjamin tenOever and Kohei Oishi.
Connection Strength
0.511
-
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021 03 09; 54(3):557-570.e5.
Score: 0.232
-
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020 05 28; 181(5):1036-1045.e9.
Score: 0.221
-
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021 08; 5(8):815-829.
Score: 0.059